Antimicrobial Resistance Patterns of Clinical Helicobacter pylori Isolates From Gastric Cancer Patients
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiaf400 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Yupei Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Helicobacter pylori, Helicobacter Infections, Anti-Bacterial Agents. Die Arbeit nennt 32 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
The increasing antibiotic resistance of Helicobacter pylori poses challenges in selecting effective eradication therapies for patients with gastric cancer. This study aimed to assess the antibiotic resistance patterns of clinical H. pylori strains isolated from gastric cancer patients, to guide H. pylori eradication strategies for those with residual gastric mucosa after gastrectomy.
Methods
This study enrolled 115 consecutive patients with gastric cancer who had a positive 13C urea breath test, all of whom were scheduled for gastric resection at West China Hospital of Sichuan University. Gastric mucosa samples were collected for pathological examination, H. pylori culture, and susceptibility testing using E-test and disk diffusion methods.
Results
From 115 specimens, 86 H. pylori strains were cultured (74.8% culture rate). Of the 86 patients (59 males, 27 females; median age 59, range 34–79) with successful H. pylori isolation, histopathology revealed 37 intestinal-type, 27 diffuse-type, 9 mixed-type, and 13 unclassified gastric cancers. Sixty-one patients underwent distal gastrectomy, and 25 had radical total gastrectomy. Notably, 12 patients were diagnosed at ≤45 years, including 9 females, all with signet ring cell carcinoma. Antibiotic resistance rates were rifampicin (RIF) (69.8%), metronidazole (MTZ) (75.6%), clarithromycin (CLR) (41.9%), levofloxacin (LEV) (32.6%), amoxicillin (AML) (2.3%), tetracycline (TET) (1.2%), and furazolidone (FZD) (0%).
Conclusions
H. pylori isolates from gastric cancer patients exhibited high resistance to RIF, MTZ, CLR, and LEV, but negligible resistance to AML, FZD, and TET. Given the compromised health status and need for concurrent therapies in these patients, AML- and/or minocycline-based regimens may represent a practical and effective treatment option for H. pylori eradication in gastric cancer patients with residual gastric mucosa after distal gastrectomy, to reduce the risk of metachronous gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, China.
- Laboratory of Infectious and Liver Diseases, Institute of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, China.
- Department of General Surgery and Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital of Sichuan University, Chengdu, Chi…
- Gastric Cancer Center, West China Hospital of Sichuan University, Chengdu, China.
- Division of Infectious Diseases, State Key Laboratory of Biotherapy and Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.
- Helicobacter pylori Research Laboratory, Marshall Centre for Infectious Diseases Research and Training, School of Biomedical Sciences, University of Western Australia, Perth, Australia.
ORCID-Profile: Kai Liu, Alfred Tay, Hong Li
Zitieren
APA
Zhang, Y., Liu, K., Song, X., Shen, Y., Tay, A., Marshall, B. J., Tang, H., & Li, H. (2025). Antimicrobial Resistance Patterns of Clinical Helicobacter pylori Isolates From Gastric Cancer Patients. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf400
Vancouver
Zhang Y, Liu K, Song X, Shen Y, Tay A, Marshall BJ, et al. Antimicrobial Resistance Patterns of Clinical Helicobacter pylori Isolates From Gastric Cancer Patients. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf400
BibTeX
@article{Zhang2025,
author = {Zhang, Yupei and Liu, Kai and Song, Xiaona and Shen, Yalin and Tay, Alfred and Marshall, Barry J and Tang, Hong and Li, Hong},
title = {Antimicrobial Resistance Patterns of Clinical Helicobacter pylori Isolates From Gastric Cancer Patients},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiaf400}
}
EUVIMED